BMC Pregnancy and Childbirth (Oct 2020)

SARS-COV-2 infection during pregnancy, a risk factor for eclampsia or neurological manifestations of COVID-19? Case report

  • Alejandro Garcia Rodriguez,
  • Sergio Marcos Contreras,
  • Santiago Manuel Fernandez Manovel,
  • Jose Miguel Marcos Vidal,
  • Fernando Diez Buron,
  • Camino Fernandez Fernandez,
  • Maria del Carmen Riveira Gonzalez

DOI
https://doi.org/10.1186/s12884-020-03275-2
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 3

Abstract

Read online

Abstract Background There are no published cases of tonic-clonic seizures and posterior bilateral blindness during pregnancy and Severe Acute Respiratory Syndrome (SARS) Coronavirus (COV) 2 (SARS-COV-2) infection. We do not just face new and unknown manifestations, but also how different patient groups are affected by SARS-COV-2 infection, such as pregnant women. Coronavirus Disease 2019 (COVID-19), preeclampsia, eclampsia and posterior reversible leukoencephalopathy share endothelium damage and similar pathophysiology. Case presentation A 35-year-old pregnant woman was admitted for tonic-clonic seizures and SARS-COV-2 infection. She had a normal pregnancy control and no other symptoms before tonic-clonic seizures development. After a Caesarean section (C-section) she developed high blood pressure, and we initiated antihypertensive treatment with labetalol, amlodipine and captopril. Few hours later she developed symptoms of cortical blindness that resolved in 72 h with normal brain computed tomography (CT) angiography. Conclusion The authors conclude that SARS COV-2 infection could promote brain endothelial damage and facilitate neurological complications during pregnancy.

Keywords